Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 10-2016 | 07-2016 | 04-2016 | 01-2016 | 10-2015 | |
| Operating Expenses | 332 | 263 | 263 | 789 | 310 |
| Operating Income | -332 | -263 | -263 | -789 | -310 |
| Other Income | -2 | -34 | -66 | 63 | 4 |
| Pre-tax Income | -334 | -297 | -328 | -726 | -306 |
| Net Income Continuous | -334 | -297 | -328 | -726 | -306 |
| Net Income | $-334 | $-297 | $-328 | $-726 | $-306 |
| EPS Basic Total Ops | -2.30 | 4.65 | -2.33 | -2.21 | -2.30 |
| EPS Basic Continuous Ops | -1.10 | 1.88 | -1.17 | -2.60 | -1.09 |
| EPS Diluted Total Ops | -2.30 | 4.65 | -2.33 | -2.21 | -2.30 |
| EPS Diluted Continuous Ops | -1.10 | 1.88 | -1.17 | -2.60 | -1.09 |
| EBITDA(a) | $-331 | $-263 | $-263 | $-789 | $-310 |